Difelikefalin for Hemodialysis Patients with Pruritus in Japan-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Difelikefalin for Hemodialysis Patients with Pruritus in Japan

Published:2023-10-24 Issue:11 Volume:2 Page:
ISSN:2766-5526
Container-title:NEJM Evidence
language:en
Short-container-title:NEJM Evidence

Author:

Narita Ichiei¹,Tsubakihara Yoshiharu²,Takahashi Naoko³,Ebata Toshiya⁴,Uchiyama Takuma⁵,Marumo Masaya⁵,Okamura Shota⁵,Gejyo Fumitake⁶,

Affiliation:

1. Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan

2. Graduate School of Medical Safety Management, Jikei University of Health Care Sciences, Osaka, Japan

3. Akane Foundation Omachi Tsuchiya Clinic, Hiroshima, Japan

4. Chitofuna Dermatology Clinic, Tokyo

5. Kissei Pharmaceutical Co., Ltd., Tokyo

6. Niigata University of Pharmacy and Medical and Life Sciences, Niigata, Japan

Publisher

Massachusetts Medical Society

Reference26 articles.

1. Uremic pruritus

2. Pruritus in Kidney Disease

3. Pruritus in hemodialysis patients: Results from the Japanese Dialysis Outcomes and Practice Patterns Study (JDOPPS)

4. Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)

5. A Longitudinal Study of Uremic Pruritus in Hemodialysis Patients

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of difelikefalin for pruritus in hemodialysis patients: a systematic review and meta-analysis of randomized controlled trials;Renal Failure;2024-08

2. Long-term efficacy and safety of difelikefalin in moderate-to-severe pruritus in Japanese hemodialysis patients: a 52-week open-label extension period of a phase 3 trial;Renal Replacement Therapy;2024-07-19

3. Chronic Kidney Disease–Associated Pruritus, Still a Vexing Problem;NEJM Evidence;2023-10-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3